A Study to Evaluate Safety and Pharmacokinetics of RO7198457 as a Single Agent and in Combination with Atezolizumab in Patients with Locally Advanced or Metastatic Tumors

Status

Completed

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2023-504224-26-00

Acronym

GO39733

Enrollment

Registered

2024-08-28

Start date

2018-07-03

Completion date

2025-06-16

Last updated

2025-03-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Advanced tumors

None listed

Sex/Gender

All

Age

18 Years to No maximum

Belgium, Germany

None listed

Source: EU CTIS · Data processed: Feb 4, 2026